Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact

por Donà, D., Di Chiara, C., Sharland, M.
Publicado 2020

Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream...

por Bielicki, J. A., Cromwell, D. A., Johnson, A., Planche, T., Sharland, M.
Publicado 2016

Lack of evidence for the efficacy of enhanced surveillance compared to other specific interventions to control neonatal healthcare-associated infection outbreaks

por Birt, J., Le Doare, K., Kortsalioudaki, C., Lawn, J., Heath, P. T., Sharland, M.
Publicado 2016

Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review

por Donà, D., Barbieri, E., Daverio, M., Lundin, R., Giaquinto, C., Zaoutis, T., Sharland, M.
Publicado 2020

Correction to: Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review

por Donà, D., Barbieri, E., Daverio, M., Lundin, R., Giaquinto, C., Zaoutis, T., Sharland, M.
Publicado 2020

Timing of positive blood samples does not differentiate pathogens causing healthcare-associated from community-acquired bloodstream infections in children in England: a linked retr...

por HENDERSON, K. L., MÜLLER-PEBODY, B., WADE, A., SHARLAND, M., MINAJI, M., JOHNSON, A. P., GILBERT, R
Publicado 2015

Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings

por Readman, J B, Acman, M, Hamawandi, A, Chiu, Cheng-Hsun, Sharland, M, Lindsay, J A, Standing, J F
Publicado 2023

Auditing use of antibiotics in Zimbabwean neonates

por Chimhini, G., Chimhuya, S., Madzudzo, L., Heys, M., Crehan, C., Robertson, V., Ferrand, R.A., Sado, B., Sharland, M., Walker, A.S., Klein, N., Fitzgerald, F.C.
Publicado 2020